Laser‐assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression

Background and Objective Laser‐assisted drug delivery is an emerging technology to achieve greater penetration by existing topical medications to reach desired targets in the tissue. The objective of this research was to study whether laser‐assisted delivery of Vitamin C, E, and Ferulic immediately postoperatively of fractional ablative laser could improve wound healing. Secondary objectives were to evaluate the potential molecular markers involved in this wound‐healing process. Study Design/Material and Methods A double blinded, prospective, single center, randomized split face trial of Vitamin C, E, and Ferulic topical formula #740019 to decrease postoperative recovery time in fractional ablative laser resurfacing for photo damage. Fifteen healthy men and women of ages 30–55 years were treated with the Vitamin C, E, and Ferulic acid serum to one side of face and vehicle to the other side of face, within 2 minutes immediately after fractional ablative CO 2 laser surgery and daily during the healing process. Patients were evaluated daily on days 1–7 using photographs, patient questionnaires, and molecular evaluation. Results Clinically, postoperative Vitamin C, E, and Ferulic delivery resulted in decreased edema versus vehicle on postoperative day 7 and decreased erythema versus vehicle on postoperative days 3 and 5. Molecularly, the expression of basic fibroblast growth factor (bFGF) was significantly increased at day 5 on the lesion treated with Vitamin C, E, and Ferulic acid serum compared to vehicle control on the other side. Conclusion This is first study to show that Vitamin C, E, and Ferulic acid correlate with more rapid wound healing post‐fractional ablative laser. Elevated bFGF could be involved in the Vitamin C, E, and Ferulic acid‐induced rapid wound healing. Lasers Surg. Med. 48:238–244, 2016. © 2015 Wiley Periodicals, Inc.